Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast

 Thoratec Presentation At Barclays Global Healthcare Conference To Be Webcast

PR Newswire

PLEASANTON, Calif., March 11, 2013

PLEASANTON, Calif., March 11, 2013 /PRNewswire/ --Thoratec Corporation
(NASDAQ: THOR), a world leader in device-based mechanical circulatory support
therapies to save, support and restore failing hearts, said today it will be
participating in the Barclays Global Healthcare Conference on Thursday, March
14.

Taylor C. Harris, Vice President and Chief Financial Officer, will provide an
update on the company, beginning at 8:00 a.m., Eastern Daylight Time (5:00
a.m., Pacific Daylight Time).

The presentation will be available through the conference web site at
http://cc.talkpoint.com/barc002/031213a_lp/?entity=106_HD8IHUN, or on the
company's web site at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart
failure. The company's products include the HeartMate® LVAS (Left Ventricular
Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than
20,000 devices implanted in patients suffering from heart failure. Thoratec
also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product
lines. Thoratec is headquartered in Pleasanton, California. For more
information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered
trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec
Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC,
and PediVAS is a registered trademark of Thoratec Switzerland GmbH.

SOURCE Thoratec Corporation

Website: http://www.thoratec.com
Contact: Taylor Harris, Vice President and Chief Financial Officer,
+1-925-738-0047
 
Press spacebar to pause and continue. Press esc to stop.